Fresenius Medical Care revenue and financials

FME · Xetra · EUR

€40.35Change from previous close: +0.45%Absolute change: +€0.18

Close · October 7, 2026

In the fiscal year ended December 2025, Fresenius Medical Care reported revenue of €19.63B (+1.51% year over year). Net income was €978.37M, a net margin of 5.0%.

Annual revenue · 2025: €19.63B
  1. €17.62B2021
  2. €19.4B2022
  3. €19.45B2023
  4. €19.34B2024
  5. €19.63B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+1.51%
2025 vs 2024
Net income growth
+81.88%
2025 vs 2024
Net margin
5.0%
2024: 2.8%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Cash flow · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Operating cash flow8602271,002742775163832985442127719760
Depreciation and amortization357354297358362383339372384388346393
Capital expenditure-240-190-423-192-154-146-241-165-159-134-250-137
Investing cash flow-271-169-418-54.0-142-108-119-220323-68.4-96.5-151
Financing cash flow-770-436-208-1,13579.2-139-965-477-837-290-746-412
Dividends paid-400—0.00.0-423———-349———
Share repurchases-145-347-434-151—0.0——————
Debt issued44717349872.71,102106-76.35.3-79.7297-105-161
Debt repaid-594-189-212-677-555-185-762-395-383-535-575-181
Effect of exchange rates2.118.7-32.2-16.2-70.7-22.450.8-12.4-7.7-4.5-24.016.7
Net change in cash-178-360343-464641-107-202275-80.1-235-147213
Free cash flow62036.857954962117.1591819283-6.6469623
Levered free cash flow1,136-79.2118848786-1957101,003762-444567243